MEDICOX Statistics

Total Valuation

MEDICOX has a market cap or net worth of KRW 15.50 billion. The enterprise value is 23.14 billion.

Market Cap	15.50B
Enterprise Value	23.14B

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

MEDICOX has 82.87 million shares outstanding. The number of shares has increased by 70.58% in one year.

Current Share Class	82.87M
Shares Outstanding	82.87M
Shares Change (YoY)	+70.58%
Shares Change (QoQ)	+25.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	61.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.28
P/TBV Ratio	0.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.08
EV / Sales	0.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.44

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.30.

Current Ratio	0.74
Quick Ratio	0.51
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-2.49
Interest Coverage	-4.27

Financial Efficiency

Return on equity (ROE) is -35.28% and return on invested capital (ROIC) is -7.54%.

Return on Equity (ROE)	-35.28%
Return on Assets (ROA)	-6.63%
Return on Invested Capital (ROIC)	-7.54%
Return on Capital Employed (ROCE)	-15.39%
Revenue Per Employee	379.29M
Profits Per Employee	-270.50M
Employee Count	79
Asset Turnover	0.34
Inventory Turnover	18.69

Taxes

Income Tax	-72.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.27% in the last 52 weeks. The beta is -0.13, so MEDICOX's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-66.27%
50-Day Moving Average	217.28
200-Day Moving Average	316.95
Relative Strength Index (RSI)	46.17
Average Volume (20 Days)	27,017,450

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDICOX had revenue of KRW 29.96 billion and -21.37 billion in losses. Loss per share was -344.06.

Revenue	29.96B
Gross Profit	1.86B
Operating Income	-9.43B
Pretax Income	-21.34B
Net Income	-21.37B
EBITDA	-7.37B
EBIT	-9.43B
Loss Per Share	-344.06

Full Income Statement

Balance Sheet

The company has 9.08 billion in cash and 16.73 billion in debt, giving a net cash position of -7.65 billion or -92.26 per share.

Cash & Cash Equivalents	9.08B
Total Debt	16.73B
Net Cash	-7.65B
Net Cash Per Share	-92.26
Equity (Book Value)	56.22B
Book Value Per Share	678.38
Working Capital	-5.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.41 billion and capital expenditures -313.65 million, giving a free cash flow of -6.73 billion.

Operating Cash Flow	-6.41B
Capital Expenditures	-313.65M
Free Cash Flow	-6.73B
FCF Per Share	-81.16

Full Cash Flow Statement

Margins

Gross margin is 6.20%, with operating and profit margins of -31.48% and -71.32%.

Gross Margin	6.20%
Operating Margin	-31.48%
Pretax Margin	-71.22%
Profit Margin	-71.32%
EBITDA Margin	-24.59%
EBIT Margin	-31.48%
FCF Margin	n/a

Dividends & Yields

MEDICOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-70.58%
Shareholder Yield	n/a
Earnings Yield	-137.89%
FCF Yield	-43.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 16, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 16, 2022
Split Type	Forward
Split Ratio	2

Scores

MEDICOX has an Altman Z-Score of -1.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.16
Piotroski F-Score	2